Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Other financing activities (2021)

Ocular Therapeutix (OCUL) has 2 years of Other financing activities data on record, last reported at $275000.0 in Q1 2021.

  • For Q1 2021, Other financing activities changed N/A year-over-year to $275000.0; the TTM value through Dec 2021 reached $275000.0, changed N/A, while the annual FY2023 figure was $5.2 million, N/A changed from the prior year.
  • Other financing activities reached $275000.0 in Q1 2021 per OCUL's latest filing, up from $6000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $275000.0 in Q1 2021 and bottomed at $275000.0 in Q1 2021.